

Illumina (NASDAQ:ILMN) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of Illumina (NASDAQ:ILMN) through any online brokerage.
Other companies in Illumina’s space includes: Thermo Fisher Scientific Inc (NYSE:TMO), Danaher Corp (NYSE:DHR), Agilent Technologies Inc (NYSE:A), Waters Corp (NYSE:WAT) and IQVIA Holdings Inc (NYSE:IQV).
Illumina has a consensus price target of $202.17.
The stock price for Illumina (NASDAQ: ILMN) is $227.52 last updated November 4, 2026 at 12:01 PM EST.
There are no upcoming dividends for Illumina.
Illumina does not have any upcoming earnings scheduled.
There is no upcoming split for Illumina.
Illumina is in the Health Care sector and Life Sciences Tools & Services industry. They are listed on the NASDAQ.
Illumina provides tools and services to analyze genetic material with life science and clinical lab applications. The company generates over 90% of its revenue from sequencing instruments, consumables, and services. Illumina's high-throughput...